CN Patent

CN109153980B — Vi-b型crispr酶和系统

Assigned to Massachusetts Institute of Technology · Expires 2023-04-14 · 3y expired

What this patent protects

本发明提供了用于靶向核酸的系统、方法和组合物。具体地说，本发明提供了非天然存在的或工程化的DNA或RNA靶向系统，这些非天然存在的或工程化的DNA或RNA靶向系统包含新颖的DNA或RNA靶向CRISPR效应蛋白和至少一种靶向核酸组分，如指导RNA。

USPTO Abstract

本发明提供了用于靶向核酸的系统、方法和组合物。具体地说，本发明提供了非天然存在的或工程化的DNA或RNA靶向系统，这些非天然存在的或工程化的DNA或RNA靶向系统包含新颖的DNA或RNA靶向CRISPR效应蛋白和至少一种靶向核酸组分，如指导RNA。

Drugs covered by this patent

Patent Metadata

Patent number
CN109153980B
Jurisdiction
CN
Classification
—
Expires
2023-04-14
Drug substance claim
No
Drug product claim
No
Assignee
Massachusetts Institute of Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.